fda compounding semaglutide warning september 2025 Compounded vs. FDA-approved medications: What's the difference and why it matters Ivím Health Raises Alarm as

Conflicts of Interest The authors have no potential conflicts of interest

Regardless of the healthcare professional involved, patients should always be informed about their treatment options and actively engaged in decisions that reflect their individual health goals

No, GLP-1s do not make you skinny fat, but it can be a downstream consequence

With diabetes and CKD projected to be the seventh and fifth leading cause of premature mortality worldwide by 2040, respectively [7], novel and effective treatment options are critical

These typically improve over 48 weeks but may require slower dose titration or, in some cases, discontinuation of treatment